每经AI快讯,昭衍新药(SH 603127,收盘价:31.93元)8月26日晚间发布公告称,公司第四届第十五次董事会会议于2025年8月26日以现场结合电话会议的形式召开。会议审议了《关于公司2025年半年度报告全文及摘要的议案》等文件。2024年1至12月份,昭衍新药的营业收入构成为:药物临床前研究服务占比95.0%,临床服务占比4.95%,实验动物及附属产品销售业务占比0.04%。截至发稿,...
Source Link每经AI快讯,昭衍新药(SH 603127,收盘价:31.93元)8月26日晚间发布公告称,公司第四届第十五次董事会会议于2025年8月26日以现场结合电话会议的形式召开。会议审议了《关于公司2025年半年度报告全文及摘要的议案》等文件。2024年1至12月份,昭衍新药的营业收入构成为:药物临床前研究服务占比95.0%,临床服务占比4.95%,实验动物及附属产品销售业务占比0.04%。截至发稿,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.